SCHEMBL3464239

SCHEMBL3464239

C=CCOc1c[c]ccc1OCC=C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.39
TSHR P16473 2/20 0.39
MAPK1 P28482 2/20 0.39
HSD17B10 Q99714 1/20 0.39
LIG1 P18858 1/20 0.37
KDM4E B2RXH2 2/20 0.36
GAA P10253 1/20 0.36
LMNA P02545 2/20 0.36
SLC22A1 O15245 1/20 0.36
CYP1A2 P05177 1/20 0.36
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
HTR1A P08908 1/20 0.36
CYP2D6 P10635 1/20 0.36
HTR2A P28223 1/20 0.36
SLC6A4 P31645 1/20 0.36
ADRA1A P35348 1/20 0.36
CA12 O43570 3/20 0.35
CA1 P00915 3/20 0.35
CA9 Q16790 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7688247 0.89 KDM4E (0.42) HPGDHSD17B10KDM4EGAACYP2D6
SCHEMBL3971417 0.89 KDM4E (0.46) HPGDHSD17B10KDM4EGAALMNA
SCHEMBL3554452 0.85 TSHR (0.33) HPGDTSHRMAPK1HSD17B10LIG1
SCHEMBL6197092 0.85 ALDH1A1 (0.41) HPGDTSHRMAPK1HSD17B10LIG1
SCHEMBL6601793 0.85 ALDH1A1 (0.41) HPGDTSHRMAPK1HSD17B10LIG1
SCHEMBL16395176 0.83 HTR2C (0.38) HPGDTSHRMAPK1HSD17B10LIG1
SCHEMBL16395320 0.83 HTR2C (0.38) HPGDTSHRMAPK1HSD17B10LIG1
SCHEMBL4884473 0.83 ADRA2A (0.40) HPGDTSHRMAPK1HSD17B10LIG1
SCHEMBL10928071 0.83 ADRA2A (0.40) HPGDTSHRMAPK1HSD17B10LIG1
SCHEMBL28033646 0.83 TSHR (0.36) HPGDTSHRMAPK1HSD17B10LIG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240654-A1 HYDRAZIDE DERIVATIVES CLARK RICHARD 2010-09-23 US claimed
US-20080132507-A1 Hydrazide Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-06-05 US claimed
EP-1810965-A1 HYDRAZIDE DERIVATIVES Eisai R&D Management Co., Ltd. (JP) 2007-07-25 EP claimed
US-7041388-B1 Substituted poly(arylene vinylenes), process for their preparation and their use in electroluminescent devices SEMICONDUCTORS GMBH (DE) 2006-05-09 US claimed
CN-111183143-B Compound, substrate for pattern formation, photodegradable coupling agent, pattern formation method, and method for manufacturing transistor 株式会社 尼康 2023-04-04 CN disclosed
CN-111183143-A Compound, substrate for pattern formation, photodegradable coupling agent, pattern formation method, and method for manufacturing transistor 株式会社尼康 2020-05-19 CN disclosed
US-20100240654-A1 HYDRAZIDE DERIVATIVES CLARK RICHARD 2010-09-23 US disclosed
US-20090318610-A1 ORGANIC INSULATING MATERIALS, VARNISHES FOR ORGANIC INSULATING FILM EMPLOYING THEM, ORGANIC INSULATING FILMS AND SEMICONDUCTOR DEVICES SUMITOMO BAKELITE CO., LTD (JP) 2009-12-24 US disclosed
EP-2117009-A1 ORGANIC INSULATING MATERIAL, VARNISH FOR ORGANIC INSULATING FILM USING THE SAME, ORGANIC INSULATING FILM AND SEMICONDUCTOR DEVICE Sumitomo Bakelite Co., Ltd. (JP) 2009-11-11 EP disclosed
US-20080132507-A1 Hydrazide Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-06-05 US disclosed
EP-1810965-A1 HYDRAZIDE DERIVATIVES Eisai R&D Management Co., Ltd. (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240654-A1 HYDRAZIDE DERIVATIVES H1-10, H1-4, H1-3 HPGD 437/4885TSHR 323/4885MAPK1 1086/4885
US-20080132507-A1 Hydrazide Derivatives H1-10, H1-4, H1-3 HPGD 437/4885TSHR 323/4885MAPK1 1086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.